Resveratrol does not reduce CVD risk, prolong life – A statistical point of view

Resveratrol does not reduce CVD risk, prolong life – A statistical point of view

Bibliographic Details
Main Author:	Changchun Xie
Format:	Article
Language:	English
Published:	Elsevier 2015-10-01
Series:	Contemporary Clinical Trials Communications
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451865415300090

Similar Items

Reducing Respondents’ Burden in the Czech Statistical Office from Respondents’ Point of View
by: Ivo Makalouš
Published: (2011-09-01)

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial
by: Yvo M Smulders, et al.
Published: (2021-07-01)

Prolonged standing reduces fasting plasma triglyceride but does not influence postprandial metabolism compared to prolonged sitting.
by: Charles K Crawford, et al.
Published: (2020-01-01)

Evaluating Cardiovascular Disease (CVD) risk scores for participants with known CVD and non-CVD in a multiracial/ethnic Caribbean sample
by: Amalia Hosein, et al.
Published: (2020-03-01)

Vitamin D supplementation does not improve CVD risk factors in vitamin D-insufficient subjects
by: Julia Kubiak, et al.
Published: (2018-06-01)

Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD.
by: Monique F Kilkenny, et al.
Published: (2017-01-01)

Does prolonged television viewing affect Body Mass Index? A case of the Kingdom of Saudi Arabia.
by: Mohammed Khaled Al-Hanawi, et al.
Published: (2020-01-01)

Optical and magnetic resonance studies of point defects in CVD diamond
by: D'Haenens-Johansson, Ulrika F. S.
Published: (2011)

Impact of CVD knowledge, risk perception, and barriers to healthcare on routine CVD management in Coimbatore, India
by: I. Balachandran, et al.
Published: (2015-03-01)

Positive views of aging reduce risk of developing later-life obesity
by: Becca R. Levy, et al.
Published: (2019-03-01)

RISK REGION. POINTS OF VIEW
by: VICTOR SOROCOVSCHI
Published: (2016-03-01)

Does SIRT-1 Mediate Calorie Restriction and Prolong Life? – A Mini Review
by: Kordala Anna, et al.
Published: (2014-09-01)

Self-Reducible Cu(II) Source Reagents for the CVD of Copper
by: Hsu, Peng-Fu, et al.
Published: (2001)

Does prolonged anti-inflammatory therapy reduce number of unnecessary repeat saturation prostate biopsy?
by: Giuseppe Candiano, et al.
Published: (2013-06-01)

Does trade reduce poverty? A view from Africa☆
by: Maëlan Le Goff, et al.
Published: (2014-07-01)

An SOA-based Approach to Monitoring CVD Risk
by: Kuan-Ming Chen, et al.

Statistical analysis of the EU countries from a touristic point of view
by: Demeter, T., et al.
Published: (2013-12-01)

Quality and Analysis of Small Data Sets – A Statistical Point of View
by: BK Ersbøll, et al.
Published: (2003-03-01)

Prolonged exposure of resveratrol induces reactive superoxide species–independent apoptosis in murine prostate cells
by: Sanjay Kumar, et al.
Published: (2017-10-01)

Wearable Technology To Reduce Sedentary Behavior And CVD Risk In Older Adults: A Pilot Randomized Clinical Trial
by: Roberts LM, et al.
Published: (2019-10-01)

Wearable technology to reduce sedentary behavior and CVD risk in older adults: Design of a randomized controlled trial
by: Lisa M. Krehbiel, et al.
Published: (2017-06-01)

HOW TO REDUCE DIMENSIONALITY OF DATA: ROBUSTNESS POINT OF VIEW
by: Jan Kalina, et al.
Published: (2015-04-01)

Enhanced Thermoelectric Conversion Efficiency of CVD Graphene with Reduced Grain Sizes
by: Gyumin Lim, et al.
Published: (2018-07-01)

The Study of Scheler''s Point of View of Life and Death.
by: HSIEH YI CHIN, et al.
Published: (1999)

Is physical activity maintenance from adolescence to young adulthood associated with reduced CVD risk factors, improved mental health and satisfaction with life: the HUNT Study, Norway
by: Rangul Vegar, et al.
Published: (2012-12-01)

Australians can adhere to a Mediterranean diet resulting in reduced CVD risk and maintained cognition; the MedLey trial
by: K.J. Murphy, et al.
Published: (2017-06-01)

How does resveratrol influence the genesis of some neurodegenerative diseases?
by: Ester Tellone, et al.
Published: (2016-01-01)

Magnetic resonance and optical studies of point defects in single crystal CVD diamond
by: Cruddace, Robin
Published: (2007)

Changes in CVD risk factors in the activity counseling trial
by: Meghan Baruth, et al.
Published: (2011-01-01)

The Development an Integrated CVD Risk Analysis Algorithm for Telemedicine
by: Ju-Chen Chen, et al.
Published: (2010)

Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus
by: Han Wu, et al.
Published: (2016-01-01)

Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
by: Jacqueline T Hecht, et al.
Published: (2021-03-01)

Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes
by: Jenifer Trepiana, et al.
Published: (2020-09-01)

Does depressed persons with non-cardiovascular morbidity have a higher risk of CVD? A population-based cohort study in Sweden
by: Aysha Almas, et al.
Published: (2019-11-01)

High-Intensity Training Reduces CVD Risk Factors among Rotating Shift Workers: An Eight-Week Intervention in Industry
by: Asgeir Mamen, et al.
Published: (2020-06-01)

Does productivity influence priority setting? A case study from the field of CVD prevention
by: Löfroth Emil, et al.
Published: (2008-03-01)

Exploring the Life Expectancy Increase in Poland in the Context of CVD Mortality Fall
by: Joanna Kobza PhD, MA, MD, et al.
Published: (2015-11-01)

Interpretation of CVD risk predictions in clinical practice: Mission impossible?
by: G R Lagerweij, et al.
Published: (2019-01-01)

Vascular markers among young women with CVD risk factors
by: Amilia Aminuddin, et al.
Published: (2019)

Understanding competing risks: a simulation point of view
by: Wanner Christoph, et al.
Published: (2011-06-01)